Home > Healthcare > Medical Devices > Therapeutic Devices > OTC Hearing Aids Market

OTC Hearing Aids Market Trends

  • Report ID: GMI5573
  • Published Date: Jan 2024
  • Report Format: PDF

OTC Hearing Aids Market Trends

The increasing prevalence of hearing loss has emerged as a significant catalyst propelling the growth of the market.
 

  • Deafness and hearing loss are pervasive issues affecting people across all regions and countries, as highlighted by the Word Health Organization. Currently, more than 1.5 billion individuals, constituting nearly 20% of the global population, suffer with varying degrees of hearing impairment, with 430 million experiencing disabling hearing loss. Projections indicate that by the year 2050, the number of individuals with disabling hearing loss could surpass 700 million.
     
  • Moreover, this widespread challenge is not limited to adults, as globally, 34 million children contend with deafness or hearing loss, and alarmingly, 60% of these cases are attributed to preventable causes. Thus, the magnitude and widespread nature of these statistics underscore the urgent need for comprehensive and accessible solutions to address the global impact of hearing loss across diverse age groups.
     
  • Additionally, the OTC hearing aids market plays a pivotal role in addressing this growing healthcare need. By offering a more accessible and cost-effective alternative to traditional hearing aids, it provides individuals with hearing impairments an opportunity to enhance their auditory experiences. This aligns with the broader trend of consumer empowerment in managing personal health, emphasizing the market's crucial role in meeting the rising demand for audiology devices in an increasingly auditory-challenged society.
     

Thus, as the market continues to innovate and expand, it stands at the forefront of addressing the global impact of hearing loss across diverse age groups, thereby is anticipated to augment industry expansion.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

OTC hearing aids industry size recorded USD 374.5 million in 2023 and is expected to register 5.8% CAGR from 2024 to 2032, owing to the rising geriatric population base along with the high disease burden of hearing loss.

Preset OTC hearing aids industry recorded 60.5% revenue share in 2023 and is expected to grow at a 6% CAGR through 2032, due to their user-friendly & easy-to operate features along with increased usage among patients with hearing difficulty.

North America accounted for 42.6% revenue share of the OTC hearing aids industry in 2023 and is expected to expand at 5.9% CAGR from 2024 to 2032, driven by the significant occurrence of hearing impairment, rising rate of product adoption, and growing awareness regarding hearing loss.

Audicus, Audien Hearing, Austar Hearing Science and Technology (Xiamen) Co., Ltd, Eargo Inc, GN Hearing A/S (GN Group), Hangzhou AcoSound Technology Co., Ltd, HearX Group (pty) LTD (Lexie Hearing), InnerScope Hearing Technologies Inc, Lucid Hearing (HEARING LAB TECHNOLOGY, LLC), MD Hearing, Neuheara Limited, Nuvomed Inc, Sonova Holding AG, SoundWave Hearing, LLC, Starkey, WS Audiology Denmark A/S, Xiamen Melosound Technology Co.Ltd. are some of the major OTC hearing aids companies worldwide.

OTC Hearing Aids Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 17
  • Tables & Figures: 200
  • Countries covered: 33
  • Pages: 175
 Download Free Sample